Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.050
-0.110 (-3.48%)
At close: Mar 13, 2026, 4:00 PM EDT
3.070
+0.020 (0.66%)
After-hours: Mar 13, 2026, 4:10 PM EDT
Exagen Stock Forecast
Stock Price Forecast
The 7 analysts that cover Exagen stock have a consensus rating of "Strong Buy" and an average price target of $9.14, which forecasts a 199.67% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $10.
Price Target: $9.14 (+199.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exagen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +227.87% | Mar 11, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +227.87% | Mar 11, 2026 |
| Keybanc | Keybanc | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +227.87% | Mar 11, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +195.08% | Mar 10, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +227.87% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
67.32M
from 55.64M
Increased by 20.99%
Revenue Next Year
74.90M
from 67.32M
Increased by 11.27%
EPS This Year
-0.92
from -0.83
EPS Next Year
-0.48
from -0.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 70.8M | 83.0M | ||||
| Avg | 67.3M | 74.9M | ||||
| Low | 64.9M | 68.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 27.2% | 23.2% | ||||
| Avg | 21.0% | 11.3% | ||||
| Low | 16.6% | 2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.93 | -0.30 | |||
| Avg | -0.92 | -0.48 | |||
| Low | -0.94 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.